Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07805759) titled 'Daydrop(R) Triple Action for Allergic Eye Symptoms' on Sept. 1.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: i+Med S.Coop.

Condition: Allergic Conjunctivitis of Both Eyes

Intervention: Device: Eye Drops, Lubricant

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: June 8, 2026

Target Sample Size: 49

Countries of Recruitment: Spain

To know more, visit https://clinicaltrials.gov/study/NCT07805759

Disclaimer: Curated by HT Syndication....